Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal dominant disorder caused by mutations in the LOXL1 gene, encoding lysyl oxidase homolog 1. The condition is characterized by abnormal fibrillar extracellular material in anterior segment tissues, and may lead to glaucoma.
Biomarker and diagnostic research for exfoliation syndrome has been reported in the published literature.
20 clinical trials registered, 11 recruiting. Interventions under study include medical devices, procedural interventions, other interventions, and drug therapy. Pipeline includes 1 PHASE4, 1 PHASE1, 11 NA. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06523751](https://clinicaltrials.gov/study/NCT06523751) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:55 PM UTC
European rare disease database
Trabeculopuncture as Predictive Test for the Success of Ab Interno Trabeculectomy |
NA |
Wuerzburg University Hospital |
RECRUITING |
[NCT04416724](https://clinicaltrials.gov/study/NCT04416724) | Phacoemulsification vs SLT as Initial Treatment for Pseudoexfoliation Glaucoma | NA | Nova Scotia Health Authority | RECRUITING |
[NCT04635020](https://clinicaltrials.gov/study/NCT04635020) | Comparison Of iStent to Laser in Exfoliation Glaucoma Helsinki Study Group | NA | Helsinki University Central Hospital | RECRUITING |
[NCT06691555](https://clinicaltrials.gov/study/NCT06691555) | Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt | — | Davinci LTD | RECRUITING |
[NCT06053554](https://clinicaltrials.gov/study/NCT06053554) | Outcome of Two Surgical Methods for IOLImplantation in Eyes With Pseudoexfoliation Syndrome | NA | Medical University of Vienna | RECRUITING |
263 publications have been identified in PubMed for exfoliation syndrome. Kisho has analyzed 87 by research type. Research spans Basic Science / Preclinical (26%), Epidemiology / Natural History (20%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 23 | 26% |
Disease patterns and progression | 17 | 20% |
Research summaries | 16 | 18% |
Testing and diagnosis research | 12 | 14% |
Clinical study results | 11 | 13% |
Patient case studies | 4 | 5% |
Other research | 2 | 2% |
New treatment approaches | 2 | 2% |
Fujita A (2026). [PMID: 41015089](https://pubmed.ncbi.nlm.nih.gov/41015089/). *Ophthalmology*. [Epidemiology / Natural History]
Karakiraz A (2026). [PMID: 41948426](https://pubmed.ncbi.nlm.nih.gov/41948426/). *J Ophthalmol*. [Diagnostic / Biomarker]
Bai Y (2026). [PMID: 41803548](https://pubmed.ncbi.nlm.nih.gov/41803548/). *Eye (Lond)*. [Other]
Bektas C (2026). [PMID: 41182003](https://pubmed.ncbi.nlm.nih.gov/41182003/). *J Glaucoma*. [Clinical Trial Publication]
Guo Z (2026). [PMID: 41548831](https://pubmed.ncbi.nlm.nih.gov/41548831/). *Exp Eye Res*. [Review / Meta-Analysis]
Liegl C (2026). [PMID: 40828215](https://pubmed.ncbi.nlm.nih.gov/40828215/). *Acta Ophthalmol*. [Clinical Trial Publication]
Kolovos A (2026). [PMID: 41130539](https://pubmed.ncbi.nlm.nih.gov/41130539/). *Ophthalmol Glaucoma*. [Epidemiology / Natural History]
Sun E (2026). [PMID: 41884873](https://pubmed.ncbi.nlm.nih.gov/41884873/). *Clin Ophthalmol*. [Epidemiology / Natural History]
Bari A (2026). [PMID: 41665897](https://pubmed.ncbi.nlm.nih.gov/41665897/). *J Cataract Refract Surg*. [Diagnostic / Biomarker]
Elsayed OA (2025). [PMID: 39549468](https://pubmed.ncbi.nlm.nih.gov/39549468/). *Vision Res*. [Review / Meta-Analysis]